s-propylcysteine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CC; Yin, MC | 1 |
| Mong, MC; Yin, MC | 1 |
2 other study(ies) available for s-propylcysteine and Alloxan Diabetes
| Article | Year |
|---|---|
Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice.
Topics: Albuminuria; Animals; Arginine; Blood Glucose; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Kidney; Lysine; Male; Mice; Mice, Inbred BALB C; Organ Size; Vascular Endothelial Growth Factor A | 2008 |
Nuclear factor κB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Cysteine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprostone; Kidney; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Reactive Oxygen Species | 2012 |